Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases

Inflammatory bowel diseases (IBD), encompassing ulcerative colitis (UC), and Crohn’s disease (CD), are a group of disorders characterized by chronic, relapsing, and remitting, or progressive inflammation along the gastrointestinal tract. IBD is accompanied by massive infiltration of circulating leuk...

Descripción completa

Detalles Bibliográficos
Autores principales: Luzentales-Simpson, Matthew, Pang, Yvonne C. F., Zhang, Ada, Sousa, James A., Sly, Laura M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887288/
https://www.ncbi.nlm.nih.gov/pubmed/33614645
http://dx.doi.org/10.3389/fcell.2021.612830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887288/
https://www.ncbi.nlm.nih.gov/pubmed/33614645
http://dx.doi.org/10.3389/fcell.2021.612830

Ejemplares similares